跳至主要内容

Clinical Implications of Tumor Necrosis Factor-Alpha, Interleukin-6 and Resistin in Coronary Artery Disease

Read full paper at:
http://www.scirp.org/journal/PaperInformation.aspx?PaperID=48852#.VKIVucCAM4

Author(s)  
Tumor necrosis factor alpha (TNF-alpha) and interleukin-6 (IL-6) are involved in the progression of coronary artery disease (CAD). The cytokines’ levels are associated with the severity of CAD. We have recently reported on the association of resistin, a relatively novel cytokine with the pathogenesis of cardiovascular disease (CVD). Although the inflammatory cytokines’ impact on atherosclerosis is widely accepted, yet some controversy exists regarding the involvement of these factors in atherogenesis. The current review highlights the potential association of TNF-alpha, IL-6 and resistin SNPs (single nucleotide polymorphisms) with CAD. Molecular genetics data along with the intracellular signaling cascade mechanisms may have important clinical implications in the treatment of CAD.
Cite this paper
Javed, Q. (2014) Clinical Implications of Tumor Necrosis Factor-Alpha, Interleukin-6 and Resistin in Coronary Artery Disease. World Journal of Cardiovascular Diseases, 4, 416-421. doi: 10.4236/wjcd.2014.49052.
 

[1] Tracy, R.P. (2003) Thrombin, Inflammation and Cardiovascular Disease. Chest, 124, 49S-57S.
http://dx.doi.org/10.1378/chest.124.3_suppl.49S
[2] Braunwald, E. (2008) Review Article: Biomarkers in Heart Failure. New England Journal of Medicine, 358, 2148-2159.
http://dx.doi.org/10.1056/NEJMra0800239
[3] Egashira, K. (2003) Molecular Mechanisms Mediating Inflammation in Vascular Disease: Special Reference to Monocyte Chemoattractant Protein-1. Hypertension, 41, 834-841.
http://dx.doi.org/10.1161/01.HYP.0000051642.65283.36
[4] Hansson, G.K. (2005) Review Article: Inflmmation, Atherosseclerosis and Coronary Artery Disease. New England Journal of Medicine, 352, 1685-1695.
http://dx.doi.org/10.1056/NEJMra043430
[5] Padovani, J.C., Pazin-Filho, A., Simoes, M.V., Marin-Neto, J.A., Zago, M.A. and Franco, R.F. (2000) Gene Polymorphisms in the TNF Locus and the Risk of Myocardial Infarction. Thrombosis Research, 100, 263-269.
http://dx.doi.org/10.1016/S0049-3848(00)00315-7
[6] Pearson, T.A., George, A., Mensah, G.A., Alexander, R.W., Anderson, J.L., Cannon, R.O., et al. (2003) Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice; A Statement for Healthcare Professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation, 107, 499-511.
http://dx.doi.org/10.1161/01.CIR.0000052939.59093.45
[7] Calabrese, F., Elisa, C., Cristina, C., et al. (2004) Over Expression of Tumor Necrosis Factor (TNF-a) and TNF-a Receptor-1 in Human Viral Myocarditis: Clinicopathologic Correlations. Mordern Pathology, 17, 1108-1118.
http://dx.doi.org/10.1038/modpathol.3800158
[8] Levine, B., Kalman, J., Mayer, L., et al. (1990) Elevated Circulating Levels of Tumor Necrosis Factor in Severe Chronic Heart Failure. New England Journal of Medicine, 323, 236-241.
http://dx.doi.org/10.1056/NEJM199007263230405
[9] Elahi, M.M. and Matata, B.M. (2005) Genetic Diversity of Tumour Necrosis Factor: Implications on Cardiovascular Complications of Polymorphisms at Position –308 in the Promoter Region. The Cardiology, 1, 179-188.
[10] Brinkman, B.M. (1996) Relevance of the Tumor Necrosis Factor Alpha (TNF Alpha) –308 Promoter Polymorphism in TNF Alpha Gene Regulation. Journal of Inflammation, 46, 32-41.
[11] Patel, R., Lim, D.S., Reddy, D., Nagueh, S.F., Lutucuta, S., Sole, M.J., et al. (2000) Variants of Trophic Factors and Expression of Cardiac Hypertrophy in Patients with Hypertrophic Cardiomyopathy. Journal of Molecular and Cellular Cardiology, 32, 2369-2377.
http://dx.doi.org/10.1038/sj.ejhg.5201816
[12] Mellick, G.D. (2007) TNF Gene Polymorphism and Quantitative Trait Related to Cardiovascular Diseases: Getting to the Heart of the Matter. European Journal of Human Genetics, 15, 609-611.
http://dx.doi.org/10.1038/sj.ejhg.5201816
[13] Deswal, A., Petersen, N.J., Feldman, A.M., Young, J.B., White, B.G. and Mann, D.L. (2001) Cytokines and Cytokine Receptors in Advanced Heart Failure: An Analysis of the Cytokine Database from the Vesnarinone Trial (VEST). Circulation, 103, 2055-2059.
http://dx.doi.org/10.1161/01.CIR.103.16.2055
[14] Torre-Amione, G., Kapadia, S., Benedict, C., Oral, H., Young, J.B. and Manna, D.L. (1996) Proinflammatory Cytokine Levels in Patients with Depressed Left Ventricular Ejection Fraction: A Report from the Studies of Left Ventricular Dysfunction (SOLVD). Journal of American College of Cardiology, 27, 1201-1206.
http://dx.doi.org/10.1016/0735-1097(95)00589-7
[15] Kubota, T., McNamara, D.M., Wang, J.J., Trost, M., McTiernan, C.F., Mann, D.L., et al. (1998) Effects of Tumor Necrosis Factor Gene Polymorphisms on Patients with Congestive Heart Failure. Circulation, 97, 2499-2501.
http://dx.doi.org/10.1161/01.CIR.97.25.2499
[16] Bidwell, J., Keen, L., Gallagher, G., Kimberly, R., Huizinga, T., McDermott, M.F., et al. (1999) Cytokine Gene Polymorphism in Human Disease: On-Line Databases. Immunology, 1, 3-19.
[17] Castell, J.V., Gómez-Lechón, M.J., David, M., Andus, T., Geiger, T., Trullenque, R., et al. (1989) Interleukin-6 Is the Major Regulator of Acute Phase Protein Synthesis in Adult Human Hepatocytes. FEBS Letters, 242, 237-239.
http://dx.doi.org/10.1016/0014-5793(89)80476-4
[18] Harris, T.B., Ferrucci, L., Tracy, R.P., Corti, M.C., Wacholder, S., Ettinger, W.H., et al. (1999) Associations of Elevated Interleukin-6 and C-Reactive Protein in Levels with Mortality in the Elderly. American Journal of Medicine, 106, 506-512.
http://dx.doi.org/10.1016/S0002-9343(99)00066-2
[19] Biasucci, L.M., Liuzzo, G., Grillo, R.L., Caligiuri, G., Rebuzzi, A.G., Buffon, A., et al. (1999) Elevated Levels of C-Reactive Protein at Discharge in Patients with Unstable Angina Predict Recurrent Instability. Circulation, 99, 855-860.
http://dx.doi.org/10.1161/01.CIR.99.7.855
[20] Biasucci, L.M., Liuzzo, G., Fantuzzi, G., Caligiuri, G., Rebuzzi, A.G., Ginnetti, F., et al. (1999) Increasing Levels of Interleukin (1L)-1Ra and IL-6 during the First Two Days of Hospitalization in Unstable Angina Are Associated with Increased Risk of IN-Hospital Coronary Events. Circulation, 99, 2079-2084.
http://dx.doi.org/10.1161/01.CIR.99.16.2079
[21] Tappia, P.S., Man, W.J. and Grimble, R.F. (1995) Influence of Unsaturated Fatty Acids on the Production of Tumour Necrosis Factor and Interleukin-6 by Rat Peritoneal Macrophages. Molecular and Cell Biochemistry, 143, 89-98.
http://dx.doi.org/10.1007/BF01816941
[22] Maes, M., Song, C., Lin, A., De Jongh, R., Van Gastel, A., Kenis, G., et al. (1998) The Effects of Psychological Stress on Humans: Increased Production of Pro-Inflammatory Cytokines and Th1-Like Response in Stress-Induced Anxiety. Cytokine, 10, 313-318.
http://dx.doi.org/10.1006/cyto.1997.0290
[23] Fishman, D., Faulds, G., Jeffery, R., Mohamed-Ali, V., Yudkin, J.S., Humphries, S., et al. (1998) The Effect of Novel Polymorphisms in the Interleukin-6 (IL-6) Gene on IL-6 Transcription and Plasma IL-6 Levels, and an Association with Systemic-Onset Juvenile Chronic Arthritis. Journal of Clinical Investigation, 102, 1369-1376.
http://dx.doi.org/10.1172/JCI2629
[24] Losito, A., Kalidas, K., Santoni, S. and Jeffery, S. (2003) Association of Interleukin-6 ﹣174G/C Promoter Polymorphism with Hypertension and Left Ventricular Hypertrophy in Dialysis Patients. Kidney International, 64, 616-622.
http://dx.doi.org/10.1046/j.1523-1755.2003.00119.x
[25] Humphries, S.E., Luong, L.A., Ogg, M.S., Hawe, E. and Miller, G.J. (2001) The Interleukin-6 174 G/C Polymorphism Is Associated with Risk of Coronary Heart Disease and Systolic Blood Pressure in Healthy Men. European Heart Journal, 22, 2243-2252.
http://dx.doi.org/10.1161/hq0901.094280
[26] Brull, D.J., Montgomery, H.E., Sanders, J., Dhamrait, S., Luong, L., Rumley, A., et al. (2001) Interleukin-6 Gene ﹣174G > C and ﹣572G > C Promoter Polymorphisms Are Strong Predictors of Plasma Interleukin-6 Levels after Coronary Artery Bypass Surgery. Arteriosclerosis, Thrombosis, and Vascular Biology, 21, 1458-1463.
http://dx.doi.org/10.1161/hq0901.094280
[27] Hussain, M., Asghar, M. and Javed, Q. (2010) Resistin Gene Promoter Region Polymorphism and the Risk of Hypertrophic Cardiomyopathy in Patients. Translational Research, 155, 142-147.
http://dx.doi.org/10.1016/j.trsl.2009.10.002
[28] Hussain, M., Bibi, S. and Javed, Q. (2011) Heritability of Genetic Variants of Resistin Gene in Patients with Coronary Artery Disease: A Family-Based Study. Clinical Biochemistry, 44, 618-622.
http://dx.doi.org/10.1016/j.clinbiochem.2011.02.013
[29] Sheth, T., Nair, C., Nargundkar, M., Anand, S. and Yusuf, S. (1999) Cardiovascular and Cancer Mortality Canadians of European, South Asian, and Chinese Origin from 1979 to 1993: An Analysis of 1.2 Million Deaths. Canadian Medical Association Journal, 161, 132-138.
[30] McPherson, R., Pertsemlidis, A., Kavaslar, N., Stewart, A., Roberts, R., Cox, D.R., et al. (2007) A Common Allele on Chromosome 9 Associated with Coronary Heart Disease. Science, 316, 1488-1491.
http://dx.doi.org/10.1126/science.1142447
[31] Helgadottir, A., Thorleifsson, G., Manolescu, A., Gretarsdottir, S., Blondal, T., Jonasdottir, A., et al. (2007) A Common Variant on Chromosome 9p21 Affects the Risk of Myocardial Infarction. Science, 316, 1491-1493.
http://dx.doi.org/10.1126/science.1142842
[32] Preuss, M., Konig, I.R., Thompson, J.R., Erdmann, J., Absher, D., Assimes, T.L., et al. (2010) Design of the Coronary Artery Disease Genome-Wide Replication and Meta-Analysis (CARDIoGRAM) Study: A Genome-Wide Association Meta-Analysis Involving More than 22 000 Cases and 60 000 Controls. Circulation: Cardiovascular Genetics, 3, 1369-1376.
http://dx.doi.org/10.1161/CIRCGENETICS.109.899443
[33] Zhuang, J., Peng, W., Li, H., Wang, W., Wei, Y., Li, W. and Xu, Y. (2012) Methylation of p15INK4b and Expression of ANRIL on Chromosome 9p21 Are Associated with Coronary Artery Disease. PLoS ONE, 7, e47193.
http://dx.doi.org/10.1371/journal.pone.0047193
[34] Javed, Q. and Murtaza, I. (2013) Therapeutic Potential of Tumor Necrosis Factor-Alpha Antagonists in Patients with Chronic Heart Failure. Heart, Lung and Circulation, 22, 323-327.
http://dx.doi.org/10.1016/j.hlc.2012.12.002               eww141230lx

评论

此博客中的热门博文

Does Immigration Promote the Investment of the Monopolistic Firm?

In the present paper, we examine the effect of increasing uncertainty of immigrants’ growth on the optimal timing of investment of a firm that has a monopolistic power over the labor market. It is revealed that when the uncertainty of immigrants’ growth is more than a threshold level, increasing uncertainty of immigrants’ growth accelerates the optimal timing of firms’ investment and enhances the economic growth, even if the uncertainty of immigrants’ growth is formulated by the geometric Brownian motion, which is in sharp contrast to the standard result that an increase in the uncertainty postpones the optimal timing. With an increase in the immigrants over the past ten years, workforces in the host countries have been growing significantly to the extent that the immigrants represent 70% of the increase in the workforce in Europe, and 47% in the United States as OECD indicates. In the present paper, we attempted to investigate the effect of increased uncertainty caused by the growi...

Education Policy Implementation: A Mechanism for Enhancing Primary Education Development in Zanzibar

Education is one of the fundamental rights of individuals; therefore, the government of a country needs to develop and strengthen educational policy and quality as well as to ensure that everyone has equal access to basic education. The improvement of access and quality of education in the world is becoming as an essential factor in development, whereas the basic education (primary school), is acknowledged as a foundation of the higher educational development for every country. To fulfill this goal, governments introduce several policies and procedures; however, it requires some reforms and participation from the politician, policymakers, and other stakeholders to re-examine educational policy so that it can lead to multiplication and betterment of the reforms. Educational reforms actually focus on accountability. A positive educational development and reform is very challenging and needs more effort and strategy on how to use and utilize the resources effectively as such it can achie...